Moreover, it has been reported that chemotherapy might induce hyperammonemia by CPS1 deficiency and, consequently, there is the need for urgent therapeutic strategies addressing a possible secondary urea cycle failure in patients affected by hyperammonemia during chemotherapy and stem cell transplantation [29]. The gene discussed is CPS1; the disease is Hyperammonemia.